Sino Biopharmaceutical | 1177 - Assets

Stock Price
5.54
Daily Change
-0.14 -2.46%
Monthly
-5.30%
Yearly
44.27%
Q2 Forecast
5.50

Sino Biopharmaceutical reported CNY74.89B in Assets for its fiscal semester ending in June of 2025.





Assets Change Date
Akebia Therapeutics USD 376.56M 12.41M Dec/2025
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
Avita Medical AUD 56.39M 1.74M Dec/2025
Cspc Pharmaceutical CNY 46.7B 695.56M Dec/2025
Dianthus Therapeutics USD 530.92M 46.52M Dec/2025
Ionis Pharmaceuticals USD 3.52B 490.91M Dec/2025
IQVIA Holdings USD 29.94B 1.22B Dec/2025
Jiangsu Hengrui CNY 71.29B 1.43B Mar/2026
Moderna USD 12.34B 203M Dec/2025
Organon & Co USD 13.55B 52M Sep/2025
Revvity USD 12.17B 29.46M Dec/2025
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
Tectonic Therapeutic USD 261.04M 15.96M Dec/2025
Viatris USD 37.19B 727.3M Dec/2025
Xeris Pharmaceuticals USD 383.53M 13.34M Dec/2025